Historically, gastric cancer has been a disease primarily affecting the elderly. However, emerging research indicates a dramatic change: younger adults are now increasingly at risk, with cases becoming more aggressive in this demographic.
TerrAscend Q1 Revenue Lifts 1% Sequentially to $69.4 Million
TerrAscend Reports Record First Quarter 2023 Revenue First quarter 2023 record Net Revenue of $69.4 million, an increase of 42.8% year-over-year 6th consecutive quarter of